Hope is Important
These are challenging times. And we at ECAN are keeping our focus trained on the positive difference we can [...]
Immunotherapy Breakthroughs for Esophageal Cancer Patients
The early results of two large, Phase III clinical trials of the immunotherapy Opdivo (nivolumab) showed significant survival benefits for [...]
Barrett’s Esophagus and Esophageal Adenocarcinoma can run in Families
The familial connection is one of the Strongest Indicators of Risk according to Experts. ECAN spoke with the Leading Researcher [...]
Don’t Be a Turkey!
Thanksgiving is during GERD Awareness Week! Show your gratitude by sharing a life-saving message with someone you are thankful for! [...]
ECAN Advocates Convince Congress to Include Esophageal Cancer in a Multi-Million Dollar Research Fund
For the second year in a row, thousands of ECAN advocates made their voices heard and convinced lawmakers in the [...]
A Survivor’s Story
Gary Gilbert of York, Pennsylvania was 72 when he was diagnosed with Stage III Esophageal Adenocarcinoma. This is his story.